SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-045200
Filing Date
2024-05-20
Accepted
2024-05-20 16:17:47
Documents
14
Period of Report
2024-05-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0206571-8k_bimihold.htm   iXBRL 8-K 29132
2 PRESS RELEASE DATED MAY 20, 2024 ea020657101ex99-1_bimihold.htm EX-99.1 6232
  Complete submission text file 0001213900-24-045200.txt   211689

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bimi-20240517.xsd EX-101.SCH 3009
4 XBRL LABEL FILE bimi-20240517_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bimi-20240517_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0206571-8k_bimihold_htm.xml XML 3672
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI Holdings Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 24964743
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)